Drugmakers’ stock prices up over swine flu fear

Published: 2009-04-30 06:59:00

Updated: 2009-04-30 06:59:00

Pharmaceutical firms and related suppliers are seeing a rise in their stock prices as the World Health Organization has recently raised the alert level to Phase 4, meaning there is sustained human-to-human transmission of the virus causing outbreaks in at least one country.

Putting an alert a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK